Back to Main

uniQure prices IPO at $17, above the range

By: Renaissance Capital
Posted: 2/5/2014 9:53:00 AM
Referenced Stocks: QURE

uniQure, a biotech developing gene therapies for the treatment of orphan diseases, raised $92 million by offering 5.4 million shares at $17, above the range of $13-$15. uniQure plans to list on the NASDAQ under the symbol QURE. Jefferies and Leerink Partners acted as lead managers on the deal.